Jacobus Burggraaf

9.8k total citations · 1 hit paper
274 papers, 6.7k citations indexed

About

Jacobus Burggraaf is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jacobus Burggraaf has authored 274 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 45 papers in Surgery and 44 papers in Molecular Biology. Recurrent topics in Jacobus Burggraaf's work include Nanoplatforms for cancer theranostics (16 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Cancer Research and Treatments (11 papers). Jacobus Burggraaf is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Cancer Research and Treatments (11 papers). Jacobus Burggraaf collaborates with scholars based in Netherlands, United States and France. Jacobus Burggraaf's co-authors include Adam F. Cohen, Rik C. Schoemaker, Matthijs Moerland, Alexander L. Vahrmeijer, Hanno Pijl, Marieke L. de Kam, Robert Rißmann, Martijn B. A. van Doorn, J. Sven D. Mieog and Marijke Frölich and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jacobus Burggraaf

268 papers receiving 6.6k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fundamentals and developments in fluorescence-guided cancer surgery

2021 251 citations J. Sven D. Mieog, Friso B. Achterberg et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacobus Burggraaf Netherlands	43	1.4k	932	868	863	836	274	6.7k
Iain C. Macdougall United Kingdom	49	1.7k 1.2×	931 1.0×	966 1.1×	1.0k 1.2×	297 0.4×	187	12.0k
Kai Zacharowski Germany	51	1.3k 0.9×	1.7k 1.8×	670 0.8×	1.1k 1.2×	511 0.6×	456	9.5k
Xue Qin China	37	2.3k 1.7×	696 0.7×	472 0.5×	588 0.7×	335 0.4×	348	6.3k
Kálmán Tóth Hungary	37	1.2k 0.9×	1.1k 1.1×	614 0.7×	750 0.9×	338 0.4×	185	4.8k
Kari Pulkki Finland	47	2.0k 1.5×	1.2k 1.3×	747 0.9×	491 0.6×	379 0.5×	206	8.0k
Soo‐Youn Lee South Korea	41	2.4k 1.7×	981 1.1×	356 0.4×	708 0.8×	497 0.6×	396	7.3k
Venkatesh Mani United States	44	917 0.7×	1.1k 1.2×	608 0.7×	1.7k 1.9×	615 0.7×	136	6.4k
Angelo Zinellu Italy	43	1.9k 1.4×	553 0.6×	1.0k 1.2×	1.4k 1.6×	423 0.5×	362	7.6k
Tatsuya Nakatani Japan	47	2.1k 1.5×	2.1k 2.3×	644 0.7×	1.4k 1.6×	268 0.3×	567	9.4k

Countries citing papers authored by Jacobus Burggraaf

Since Specialization

Citations

This map shows the geographic impact of Jacobus Burggraaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacobus Burggraaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacobus Burggraaf more than expected).

Fields of papers citing papers by Jacobus Burggraaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacobus Burggraaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacobus Burggraaf. The network helps show where Jacobus Burggraaf may publish in the future.

Co-authorship network of co-authors of Jacobus Burggraaf

This figure shows the co-authorship network connecting the top 25 collaborators of Jacobus Burggraaf. A scholar is included among the top collaborators of Jacobus Burggraaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacobus Burggraaf. Jacobus Burggraaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schomann, Timo, Mireille Vankemmelbeke, Lindy G. Durrant, et al.. (2025). Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers. EJNMMI Research. 15(1). 67–67. 1 indexed citations

Klarenbeek, Naomi B., Philip H. C. Kremer, Manon A. A. Jansen, et al.. (2025). Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience. British Journal of Clinical Pharmacology. 1 indexed citations

Grievink, Hendrika W., Thierry van den Bosch, Jeffrey Damman, et al.. (2025). Profiling a Neo‐Antigen‐Driven Immune Response in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled Study of the KLH Challenge Model. Clinical Pharmacology & Therapeutics. 118(5). 1132–1142.

Meziyerh, Soufian, Aiko P. J. de Vries, Mariet C.W. Feltkamp, et al.. (2024). Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treatment. Clinical and Translational Science. 17(6). e13860–e13860. 3 indexed citations

Bijlstra, Okker D., James P. Basilion, Matthew Bogyo, et al.. (2024). Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients. Molecular Imaging and Biology. 26(6). 1057–1067. 2 indexed citations

Gal, Pim, W. Bakker, Geert Jan Groeneveld, et al.. (2024). Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat Stress. Journal of Experimental Pharmacology. Volume 16. 285–294. 1 indexed citations

Jansen, Manon A. A., Marieke L. de Kam, Dirk Jan A. R. Moes, et al.. (2023). Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using Ex Vivo T Cell Function Assays. Pharmaceutics. 15(6). 1635–1635. 3 indexed citations

Jansen, Manon A. A., Marieke L. de Kam, Dirk Jan A. R. Moes, et al.. (2022). Monitoring of Ex Vivo Cyclosporin a Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics. Pharmaceutics. 14(9). 1958–1958. 3 indexed citations

Mieog, J. Sven D., Friso B. Achterberg, Aimen Zlitni, et al.. (2021). Fundamentals and developments in fluorescence-guided cancer surgery. Nature Reviews Clinical Oncology. 19(1). 9–22. 251 indexed citations breakdown →

10.

Valk, Kim S. de, Marion M. Deken, Henricus J.M. Handgraaf, et al.. (2020). First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma. Clinical Cancer Research. 26(15). 3990–3998. 77 indexed citations

11.

Grievink, Hendrika W., Frederik E. Stuurman, Marieke L. de Kam, et al.. (2019). Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?. International Journal of Molecular Sciences. 20(19). 4710–4710. 13 indexed citations

12.

Kolk, Tessa Niemeyer‐van der, Martijn B. A. van Doorn, Jacobus Burggraaf, et al.. (2019). Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis. Acta Dermato Venereologica. 100(1). 1–2. 5 indexed citations

13.

Wopereis, Suzan, Johanna H. M. Stroeve, Annette Stafleu, et al.. (2017). Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge. Genes & Nutrition. 12(1). 21–21. 72 indexed citations

14.

Hoogstins, Charlotte E.S., Quirijn R.J.G. Tummers, Katja N. Gaarenstroom, et al.. (2016). A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer. Clinical Cancer Research. 22(12). 2929–2938. 211 indexed citations

15.

Dongen, Marloes G. J. van, Bart F. Geerts, Erin Morgan, et al.. (2014). First proof of pharmacology in humans of a novel glucagon receptor antisense drug. The Journal of Clinical Pharmacology. 55(3). 298–306. 37 indexed citations

16.

Cohen, Adam F., Jacobus Burggraaf, Joop van Gerven, Matthijs Moerland, & Geert Jan Groeneveld. (2014). The Use of Biomarkers in Human Pharmacology (Phase I) Studies. The Annual Review of Pharmacology and Toxicology. 55(1). 55–74. 41 indexed citations

17.

Herpen, G. van, et al.. (2009). Short-term QT variability: A marker for reduced repolarization reserve in anthracyclin therapy. 585–588. 4 indexed citations

18.

Franson, Kari L., Eline A. Dubois, Marieke L. de Kam, Jacobus Burggraaf, & Adam F. Cohen. (2008). Creating a culture of thoughtful prescribing. Medical Teacher. 31(5). 415–419. 8 indexed citations

19.

Boot, J. D., Sanne de Haas, Christine Le Roy, et al.. (2006). Effect of an NK1/NK2 Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma. American Journal of Respiratory and Critical Care Medicine. 175(5). 450–457. 54 indexed citations

20.

Zwaveling, J., et al.. (2004). Pharmacokinetics of rectal tramadol in postoperative paediatric patients. British Journal of Anaesthesia. 93(2). 224–227. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact